Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.4509 | 71 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.36055 | 70 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.39265 | 70 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.76426 | 73 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.5607 | 72 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.65094 | 73 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.3637 | 70 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.43818 | 71 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.3286 | 70 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.8224 | 74 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.70384 | 73 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.81227 | 74 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.55955 | 72 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.52893 | 72 |